Neurodegenerative changes are associated with the pathogenesis of cognitive impairment, whereas SGLT2 inhibitors can protect the nervous system through anti-inflammatory and anti-oxidative stress effects [4, 5]. This evidence concerns the gene SLC5A2 and Cognitive impairment.